Veracyte (VCYT) Equity Ratio (2012 - 2026)

Veracyte has disclosed Equity Ratio across 15 years of filings, most recently posting 0.94 for Q1 2026.

• Equity Ratio for Q1 2026 came in at 0.94, up 3.03% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.94 (up 3.03% YoY), and the FY2025 annual result was 0.93, up 2.97% from the prior year.
• Equity Ratio came in at 0.94 for Q1 2026 at Veracyte, roughly flat from 0.93 in the prior quarter.
• In the past five years, Equity Ratio ranged from a high of 0.94 in Q3 2023 to a low of 0.9 in Q4 2024.
• The 5-year median for Equity Ratio is 0.93 (2022), against an average of 0.93.
• Across the five-year window, Equity Ratio dropped 3.41% in 2024 and increased 3.03% in 2026, its largest moves.
• Veracyte's Equity Ratio stood at 0.93 in 2022, then advanced by 0.72% to 0.94 in 2023, then fell by 3.41% to 0.9 in 2024, then increased by 2.97% to 0.93 in 2025, then increased by 0.49% to 0.94 in 2026.
• The last three Equity Ratio figures came in at 0.94 (Q1 2026), 0.93 (Q4 2025), and 0.92 (Q3 2025), per Business Quant data.